Overview
About Cherry Biotech
Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing.
Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates.
By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert a standard 2D multi-well plate into a 3D cell culture (Organ on Well).
This innovative patented technology allows for the implementation of the current regulatory change on the ethics of animal experimentation while remaining compatible with the current industry workflow.
Cherry Biotech is among the innovative projects selected and supported by the Paris Saclay Cancer Cluster (PSCC), whose mission is to accelerate the development of innovation in oncology.
We are sharing every two weeks the newsletter "Organoid Digest" with the recent news in the field : https://organoid.substack.com/
Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates.
By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert a standard 2D multi-well plate into a 3D cell culture (Organ on Well).
This innovative patented technology allows for the implementation of the current regulatory change on the ethics of animal experimentation while remaining compatible with the current industry workflow.
Cherry Biotech is among the innovative projects selected and supported by the Paris Saclay Cancer Cluster (PSCC), whose mission is to accelerate the development of innovation in oncology.
We are sharing every two weeks the newsletter "Organoid Digest" with the recent news in the field : https://organoid.substack.com/